|Bid||147.47 x 800|
|Ask||148.65 x 800|
|Day's range||145.73 - 148.62|
|52-week range||120.40 - 158.34|
|Beta (5Y monthly)||0.97|
|PE ratio (TTM)||14.57|
|Forward dividend & yield||2.64 (1.81%)|
|Ex-dividend date||17 Jan 2023|
|1y target est||N/A|
LA JOLLA, Calif. & PHOENIX, November 15, 2022--DermTech, Inc. (NASDAQ: DMTK) ("DermTech" or the "Company"), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today an agreement with Sonora Quest Laboratories (Sonora Quest), Arizona’s leading diagnostic laboratory, to expand access to enhanced melanoma detection. As a result of the agreement, Sonora Quest will be the exclusive laboratory in Arizona to offer the DermTech Melanoma Test to its vast network
TORONTO, September 14, 2022--Achievers, an industry-leading employee experience software platform, announces its joint win of a Gold award by Brandon Hall Group with its customer case study of Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services.
PHILADELPHIA & SECAUCUS, N.J., July 19, 2022--Rite Aid (NYSE: RAD) today announced it is collaborating with Quest Diagnostics (NYSE: DGX) to provide access to quality, COVID-19 molecular testing (polymerase chain reaction or similar nucleic acid amplification test) to help Rite Aid customers detect and prevent the spread of COVID-19.